---
title: "AstraZeneca initiated with an Outperform at CICC"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296709211.md"
description: "AstraZeneca initiated with an Outperform at CICC"
datetime: "2026-08-23T20:31:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296709211.md)
  - [en](https://longbridge.com/en/news/296709211.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296709211.md)
generator: "portal-rs"
---

# AstraZeneca initiated with an Outperform at CICC


### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)

## Related News & Research

- [BREAKINGVIEWS-AstraZeneca's blocked M&A signals tough CEO finale](https://longbridge.com/en/news/296766497.md)
- [AstraZeneca: Tagrisso Plus Orpathys Phase III Trial Shows PFS, OS Improvements In EGFRm Lung Cancer](https://longbridge.com/en/news/296071807.md)
- [REG - AstraZeneca PLC - Update on eVOLVE-Lung02 Phase III trial](https://longbridge.com/en/news/296062318.md)
- [AstraZeneca halts lung cancer trial of volrustomig in latest blow to pipeline](https://longbridge.com/en/news/296069146.md)
- [Sino Biopharma rebrands global operations under SBP Group identity](https://longbridge.com/en/news/296347598.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**